What are the Historical Developments and Current Growth Metrics of the Ready To Use Luria Bertani LB Liquid Medium Market?
The ready to use luria bertani lb liquid medium market has seen considerable growth due to a variety of factors.
• The market size of the ready-to-use luria-bertani (LB) liquid medium has experienced significant growth in the recent past. An increase from $10.32 billion in 2024 to $11.21 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%, is projected.
Several contributing factors have stimulated this growth, including heightened involvement in the pharmaceutical and biotechnology domains, increasing calls for advanced medical solutions, spurring demand for microbiological research, a surge in outsourcing for research and development activities, as well as intensifying needs for microbiological studies.
What is the Forecasted Market Size and CAGR for the Ready To Use Luria Bertani LB Liquid Medium Market?
The ready to use luria bertani lb liquid medium market is expected to maintain its strong growth trajectory in upcoming years.
• The market for ready-to-use luria-bertani (LB) liquid medium is projected to experience robust growth in the coming years. The market is set to expand to a value of $15.4 billion in 2029, with a compound annual growth rate (CAGR) of 8.2%.
This projected growth during the forecast period is primarily driven by its rising application in pharmaceutical and biotechnology sectors, increased requirement for cutting-edge medicines, surge in demand for microbiological research, growing propensity for outsourcing R&D activities and an elevated need for microbiological studies. Key trends predicted for the forecast period include the advancements in product customization and packaging, escalation in research and development endeavors, increased demand for standardised media, heightened adoption of automated laboratory systems, and an expanding preference for pre-mixed solutions.
What Key Factors and Trends Are Driving The Growth Ready To Use Luria Bertani LB Liquid Medium Market?
The growth of the ready-to-use Luria-Bertani (LB) liquid medium market is set to be fueled by a surge in research and development activities. These activities involve the exploration, design, testing, and refinement of new ideas or technologies to develop or enhance products or processes. The necessity of continual innovation propels businesses to invest in R&D in order for them to develop new products, enhance existing ones, and cater to evolving consumer needs. As a key tool in R&D, ready-to-use LB liquid medium is crucial for the growth of bacteria, gene cloning, protein expression, and different genetic alterations. Its ease-of-use and reliability make it indispensable for various experimental methods and large-scale research applications. For example, federal agency obligations for research and experimental development (R&D) reached a record-breaking $190.2 billion in September 2023, according to the National Center for Science and Engineering Statistics, a US-based statistics agency. This represents a 13.6% increase ($22.7 billion) from 2021. Hence, a rise in research and development activities is stimulating the progress of the ready-to-use Luria-Bertani (LB) liquid medium market. The ready-to-use Luria-Bertani (LB) liquid medium market is also being driven by an increase in clinical trials. These trials, which involve human participants, are conducted to determine the safety and efficacy of new medical interventions before they can be approved for widespread use. The growing interest in personalized medicine, which involves creating treatments tailored to individual genetic profiles and specific health conditions, is causing a surge in clinical trials. To yield accurate results, clinical trials necessitate consistent conditions that the ready-to-use LB liquid medium provides, negating the need for preparation or sterilization. This leads to a more efficient research process, particularly in high-throughput and multi-site studies. As an example, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based non-profit organization that manufactures prescription medicines for human use, shows that the number of industry clinical trials initiated in the UK increased by 4.3%, from 394 in 2021 to 411 in 2022. This demonstrates how the increasing number of clinical trials are driving the advancement of the ready-to-use Luria-Bertani (LB) liquid medium market.
What Are The Market Segments In The Ready To Use Luria Bertani LB Liquid Medium Market?
The ready-to-use luria-bertani (LB) liquid medium market covered in this report is segmented –
1) By Type: Contains Antibiotics, Antibiotic Free
2) By Application: Drug Discovery, Stem Cell Technologies, Regenerative Medicine And Tissue Engineering, Bio-Pharmaceuticals, Cancer Research, Other Applications
3) By End-User: Research Laboratories, Academic Institutes, Biotechnology And Pharmaceutical Sector, Other End-Users
Subsegments:
1) By Contains Antibiotics: LB Medium With Ampicillin, LB Medium With Kanamycin, LB Medium With Tetracycline, LB Medium With Chloramphenicol, LB Medium With Streptomycin
2) By Antibiotic Free: Standard LB Liquid Medium, LB Liquid Medium With Supplementary Nutrients, LB Liquid Medium For Fast-Growing Bacteria, LB Liquid Medium For Low-Temperature Growth
Pre-Book The Ready To Use Luria Bertani LB Liquid Medium Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Ready To Use Luria Bertani LB Liquid Medium Market?
Leading firms in the ready-to-use Luria-Bertani (LB) liquid medium market are leveraging advancements in drug discovery software to gain a distinct competitive advantage. For example, in December 2023, the Germany-headquartered pharmaceutical and biotech products company, Merck, introduced AIDDISON, an innovative drug discovery software. It employs artificial intelligence and machine learning techniques to accelerate the discovery of possible drug candidates. Boasting an intuitive interface and enhanced data analysis features, AIDDISON allows scientists to efficiently manage and comprehend massive amounts of data. This groundbreaking software could transform the drug discovery process, paving the way for speedier and more economically efficient development of new therapies.
Who Are the Key Players In The Ready To Use Luria Bertani LB Liquid Medium Market?
Major companies operating in the ready-to-use luria-bertani (LB) liquid medium market are:
• Thermo Fisher Scientific Inc.
• Avantor Inc.
• Lonza Group AG
• Sigma Aldrich Chemicals Pvt. Ltd.
• Bio-Rad Laboratories Inc.
• Neogen Corporation
• bioWORLD
• Hardy Diagnostics Inc.
• MP Biomedicals LLC
• ITW Reagents
• Alpha Teknova Inc.
• HiMedia Laboratories Pvt. Ltd.
• Scharlab S.L.
• Interchim
• Condalab
• Quality Biological Inc.
• Thomas Scientific LLC
• Geno Technology Inc.
• Central Drug House (P) Ltd.
• Citotest Labware Manufacturing Co. Ltd.
• Research Products International
• NZYTech Lda
What Are The Regional Insights Into The Ready To Use Luria Bertani LB Liquid Medium Market?
Europe was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ready-to-use Luria-bertani (LB) liquid medium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
